Exploratory experiment designed to discover new patterns targeting N/A in human patients, in vitro angiogenesis assays, in vivo angiogenesis models. Primary outcome: sEV angiogenic capability
This experiment evaluated the angiogenic properties of serum-derived extracellular vesicles (sEV) isolated from different patient populations including type 2 diabetic subjects, obese individuals with and without diabetes, and subjects with ischemic disease. The study aimed to identify patients who may benefit from autologous sEV administration for pro-angiogenic therapeutic purposes. sEV were isolated from serum samples and their angiogenic capabilities were assessed both in vitro and in vivo using appropriate angiogenesis assays. The results showed that sEV display different angiogenic properties across these patient populations, with particular differences noted in type 2 diabetic patients.
sEV isolation from serum samples, in vitro and in vivo angiogenesis assays across different patient populations
Different angiogenic properties of sEV from different patient populations
Measurable differences in angiogenic capability between patient groups
No related hypotheses
No debates yet
No results recorded yet. Use POST /api/experiments/{id}/results to record a result.